Canada - TSX Venture Exchange - TSX-V:EVMT - CA30053H1055 - Common Stock
The current stock price of EVMT.CA is 0.005 CAD. In the past year, price decreased by -97.37%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 273.82M | ||
| MIR.CA | MEDMIRA INC | N/A | 49.29M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 39.91M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 38.41M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 20.08M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 20.04M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 19.10M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.04M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 14.25M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 2.84M | ||
| IVC-H.CA | INTERCONNECT VENTURES CORP | N/A | 1.07M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K |
Evome Medical Technologies, Inc. engages in the provision of financial and consultancy services to the mental health and addiction industry. The company is headquartered in Shirley, New York and currently employs 195 full-time employees. The company went IPO on 2014-03-28. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. The company offers concussion, fall screening and balance assessment and training programs.
EVOME MEDICAL TECHNOLOGIES I
49 Natcon Drive
Shirley NEW YORK US
Employees: 195
Phone: 18007606826
Evome Medical Technologies, Inc. engages in the provision of financial and consultancy services to the mental health and addiction industry. The company is headquartered in Shirley, New York and currently employs 195 full-time employees. The company went IPO on 2014-03-28. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. The company offers concussion, fall screening and balance assessment and training programs.
The current stock price of EVMT.CA is 0.005 CAD.
EVMT.CA does not pay a dividend.
EVMT.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
The Revenue of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) is expected to decline by -0.65% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) has a market capitalization of 300.85K CAD. This makes EVMT.CA a Nano Cap stock.
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) will report earnings on 2025-08-11.
ChartMill assigns a fundamental rating of 2 / 10 to EVMT.CA. Both the profitability and financial health of EVMT.CA have multiple concerns.
Over the last trailing twelve months EVMT.CA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 4.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.99% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
For the next year, analysts expect an EPS growth of -400% and a revenue growth -0.65% for EVMT.CA